Soleus Capital Management, L.P. - Q3 2023 holdings

$1.08 Billion is the total value of Soleus Capital Management, L.P.'s 91 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 59.4% .

 Value Shares↓ Weighting
XBI NewSPDR SER TRcall$91,275,0001,250,000
+100.0%
8.42%
UTHR BuyUNITED THERAPEUTICS CORP DEL$64,861,959
+21.0%
287,165
+18.3%
5.98%
+0.5%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDsponsored ads$61,732,073
+92.9%
6,052,164
+42.4%
5.70%
+60.1%
EDAP BuyEDAP TMS S Asponsored adr$43,922,624
-13.0%
6,256,784
+14.3%
4.05%
-27.8%
SRDX SellSURMODICS INC$39,498,362
-5.6%
1,230,862
-7.9%
3.64%
-21.7%
ORGO BuyORGANOGENESIS HLDGS INC$39,101,798
+0.4%
12,296,163
+4.8%
3.61%
-16.7%
NewGSK PLCsponsored adr$34,183,750943,000
+100.0%
3.15%
HUM BuyHUMANA INC$33,473,549
+19.3%
68,802
+9.6%
3.09%
-1.0%
IRMD SellIRADIMED CORP$27,873,500
-24.5%
628,206
-18.8%
2.57%
-37.4%
PCVX SellVAXCYTE INC$25,472,157
-10.7%
499,650
-12.5%
2.35%
-25.9%
TMCI NewTREACE MED CONCEPTS INC$25,011,5601,907,823
+100.0%
2.31%
TGTX BuyTG THERAPEUTICS INC$24,113,434
+122.9%
2,884,382
+562.3%
2.22%
+85.0%
NPCE SellNEUROPACE INC$23,996,175
+116.7%
2,466,205
-0.0%
2.21%
+79.9%
SellARCELLX INC$23,098,719
-27.1%
643,777
-35.8%
2.13%
-39.5%
BuyTANGO THERAPEUTICS INC$21,720,754
+268.2%
1,929,019
+8.6%
2.00%
+205.5%
PODD NewINSULET CORP$20,363,683127,680
+100.0%
1.88%
EOLS BuyEVOLUS INC$18,992,920
+156.9%
2,078,000
+104.3%
1.75%
+113.1%
AXGN BuyAXOGEN INC$18,929,145
+15.8%
3,785,829
+111.5%
1.75%
-3.9%
CRL SellCHARLES RIV LABS INTL INC$18,826,623
-57.3%
96,064
-54.1%
1.74%
-64.5%
CELC BuyCELCUITY INC$18,796,264
-11.0%
2,056,484
+6.9%
1.73%
-26.1%
SKIN BuyTHE BEAUTY HEALTH COMPANY$16,896,454
-18.7%
2,806,720
+13.1%
1.56%
-32.5%
AXSM BuyAXSOME THERAPEUTICS INC$16,598,875
+827.7%
237,500
+853.8%
1.53%
+669.3%
SNN BuySMITH & NEPHEW PLCspdn adr new$16,197,103
+2.7%
653,900
+33.6%
1.49%
-14.8%
RIGL BuyRIGEL PHARMACEUTICALS INC$15,987,256
-12.6%
14,803,015
+4.4%
1.48%
-27.4%
IMVT BuyIMMUNOVANT INC$15,340,606
+365.8%
399,599
+130.2%
1.42%
+286.6%
KRYS BuyKRYSTAL BIOTECH INC$13,675,472
+5.7%
117,892
+7.0%
1.26%
-12.2%
SIBN BuySI-BONE INC$13,642,218
-19.2%
642,289
+2.6%
1.26%
-33.0%
CVS SellCVS HEALTH CORP$13,444,120
-45.2%
192,554
-45.8%
1.24%
-54.6%
ATRC NewATRICURE INC$13,402,800306,000
+100.0%
1.24%
EPIX BuyESSA PHARMA INC$13,247,120
+16.8%
4,287,094
+2.0%
1.22%
-3.1%
MREO NewMEREO BIOPHARMA GROUP PLCspon ads$12,483,8719,677,419
+100.0%
1.15%
BHC BuyBAUSCH HEALTH COS INC$11,580,344
+25.3%
1,408,801
+21.9%
1.07%
+3.9%
BuyVERASTEM INC$10,954,110
+182.9%
1,347,369
+158.9%
1.01%
+135.1%
BNTX NewBIONTECH SEsponsored ads$10,646,72098,000
+100.0%
0.98%
INBX BuyINHIBRX INC$10,077,508
-18.0%
549,183
+16.1%
0.93%
-31.9%
NewRAYZEBIO INC$10,015,819451,163
+100.0%
0.92%
NewSOLENO THERAPEUTICS INC$9,590,750325,000
+100.0%
0.88%
MRUS NewMERUS N V$9,066,274384,490
+100.0%
0.84%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$7,871,262
-25.1%
391,800
-4.9%
0.73%
-37.8%
BCAB BuyBIOATLA INC$7,405,535
-42.9%
4,356,197
+0.8%
0.68%
-52.6%
PHVS SellPHARVARIS N V$7,178,758
+21.0%
343,975
-12.2%
0.66%
+0.3%
CMPS NewCOMPASS PATHWAYS PLCsponsored ads$7,137,670964,550
+100.0%
0.66%
SellNUVALENT INC$7,098,504
-21.0%
154,416
-27.5%
0.66%
-34.4%
INSP BuyINSPIRE MED SYS INC$7,064,464
+224.8%
35,600
+431.3%
0.65%
+169.4%
EXAS BuyEXACT SCIENCES CORP$6,971,811
+6.8%
102,196
+47.0%
0.64%
-11.3%
NRIX NewNURIX THERAPEUTICS INC$6,398,040814,000
+100.0%
0.59%
BLFS NewBIOLIFE SOLUTIONS INC$6,062,590439,000
+100.0%
0.56%
BuyJASPER THERAPEUTICS INC$5,810,686
-45.5%
8,300,980
+6.8%
0.54%
-54.7%
IOVA  IOVANCE BIOTHERAPEUTICS INC$5,640,985
-35.4%
1,239,7770.0%0.52%
-46.4%
NVCR BuyNOVOCURE LTD$5,557,215
-45.4%
344,100
+40.4%
0.51%
-54.6%
INSM NewINSMED INC$5,504,500218,000
+100.0%
0.51%
ETNB Buy89BIO INC$5,342,750
+24.5%
346,033
+52.8%
0.49%
+3.4%
URGN NewUROGEN PHARMA LTD$5,211,720372,000
+100.0%
0.48%
ACAD BuyACADIA PHARMACEUTICALS INC$5,098,027
+222.5%
244,627
+270.6%
0.47%
+167.0%
NewTHERATECHNOLOGIES INC$5,012,4582,331,376
+100.0%
0.46%
CCCC  C4 THERAPEUTICS INC$5,007,157
-32.4%
2,692,0200.0%0.46%
-43.9%
CSTL NewCASTLE BIOSCIENCES INC$4,788,315283,500
+100.0%
0.44%
NSPR  INSPIREMD INC$4,506,479
+30.3%
1,378,1280.0%0.42%
+8.1%
TARS NewTARSUS PHARMACEUTICALS INC$4,442,500250,000
+100.0%
0.41%
MCRB SellSERES THERAPEUTICS INC$4,333,940
-55.8%
1,820,983
-11.0%
0.40%
-63.3%
MIRM SellMIRUM PHARMACEUTICALS INC$3,254,800
-28.5%
103,000
-41.5%
0.30%
-40.7%
APLT NewAPPLIED THERAPEUTICS INC$2,969,6391,192,626
+100.0%
0.27%
NewBIOHAVEN LTD$2,959,938113,800
+100.0%
0.27%
BuyGENEDX HOLDINGS CORP$2,844,281
-32.9%
781,396
+9.8%
0.26%
-44.4%
KNSA SellKINIKSA PHARMACEUTICALS LTD$2,733,152
-62.6%
157,349
-69.7%
0.25%
-69.0%
NTRA SellNATERA INC$2,715,932
-66.9%
61,377
-63.6%
0.25%
-72.5%
DSGN NewDESIGN THERAPEUTICS INC$2,419,0001,025,000
+100.0%
0.22%
LYRA  LYRA THERAPEUTICS INC$2,316,350
-4.9%
592,4170.0%0.21%
-21.0%
PRAX SellPRAXIS PRECISION MEDICINES I$1,966,500
-18.6%
1,150,000
-45.2%
0.18%
-32.5%
XENE SellXENON PHARMACEUTICALS INC$1,776,320
-30.1%
52,000
-21.2%
0.16%
-41.8%
SNDX SellSYNDAX PHARMACEUTICALS INC$1,735,140
-61.0%
119,500
-43.8%
0.16%
-67.7%
 AADI BIOSCIENCE INC$1,612,819
-29.2%
333,2270.0%0.15%
-41.1%
FDMT Sell4D MOLECULAR THERAPEUTICS IN$1,575,312
-60.2%
123,748
-43.5%
0.14%
-67.0%
ALKS SellALKERMES PLC$1,523,744
-75.0%
54,400
-72.0%
0.14%
-79.1%
VKTX SellVIKING THERAPEUTICS INC$1,352,754
-75.2%
122,200
-63.7%
0.12%
-79.4%
ANNX SellANNEXON INC$1,216,344
-44.3%
515,400
-16.9%
0.11%
-53.9%
LQDA  LIQUIDIA CORPORATION$1,109,500
-19.2%
175,0000.0%0.10%
-33.3%
RCEL  AVITA MEDICAL INC$1,095,750
-14.1%
75,0000.0%0.10%
-28.9%
KRTX SellKARUNA THERAPEUTICS INC$1,088,940
-64.5%
6,440
-54.5%
0.10%
-70.7%
AVDL SellAVADEL PHARMACEUTICALS PLCsponsored adr$1,071,200
-78.8%
104,000
-66.1%
0.10%
-82.4%
ALPN  ALPINE IMMUNE SCIENCES INC$1,008,436
+11.4%
88,0730.0%0.09%
-7.9%
YMAB  Y-MABS THERAPEUTICS INC$856,642
-19.7%
157,1820.0%0.08%
-33.6%
NewAPOGEE THERAPEUTICS INC$745,50035,000
+100.0%
0.07%
ALNY NewALNYLAM PHARMACEUTICALS INC$690,6903,900
+100.0%
0.06%
GLTO SellGALECTO INC$645,864
-74.4%
897,657
-10.2%
0.06%
-78.6%
DCTH NewDELCATH SYS INC$587,080144,958
+100.0%
0.05%
SellXERIS BIOPHARMA HOLDINGS INC$565,594
-89.5%
304,083
-85.2%
0.05%
-91.3%
SBTX NewARS PHARMACEUTICALS INC$567,000150,000
+100.0%
0.05%
 XILIO THERAPEUTICS INC$478,846
-19.5%
226,9410.0%0.04%
-33.3%
IMUX  IMMUNIC INC$441,000
-41.4%
300,0000.0%0.04%
-51.2%
KROS SellKEROS THERAPEUTICS INC$404,876
-85.8%
12,700
-82.1%
0.04%
-88.3%
STRO ExitSUTRO BIOPHARMA INC$0-25,887
-100.0%
-0.01%
ExitPARAGON 28 INC$0-10,000
-100.0%
-0.02%
TVTX ExitTRAVERE THERAPEUTICS INC$0-21,600
-100.0%
-0.04%
ExitINDIVIOR PLCord$0-18,624
-100.0%
-0.05%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-13,600
-100.0%
-0.05%
VRNA ExitVERONA PHARMA PLCsponsored ads$0-21,700
-100.0%
-0.05%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-320,000
-100.0%
-0.06%
LUNG ExitPULMONX CORP$0-41,000
-100.0%
-0.06%
PLRX ExitPLIANT THERAPEUTICS INC$0-33,500
-100.0%
-0.07%
RYTM ExitRHYTHM PHARMACEUTICALS INC$0-38,600
-100.0%
-0.07%
ExitVENTYX BIOSCIENCES INC$0-21,300
-100.0%
-0.08%
MORF ExitMORPHIC HLDG INC$0-13,600
-100.0%
-0.09%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-34,000
-100.0%
-0.09%
IMCR ExitIMMUNOCORE HLDGS PLCads$0-16,400
-100.0%
-0.11%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-39,800
-100.0%
-0.12%
ExitMINERALYS THERAPEUTICS INC$0-76,817
-100.0%
-0.15%
CERE ExitCEREVEL THERAPEUTICS HLDNG I$0-46,000
-100.0%
-0.16%
ACRS ExitACLARIS THERAPEUTICS INC$0-151,000
-100.0%
-0.17%
LLY ExitLILLY ELI & CO$0-4,300
-100.0%
-0.22%
BDTX ExitBLACK DIAMOND THERAPEUTICS I$0-435,000
-100.0%
-0.24%
CRSP ExitCRISPR THERAPEUTICS AGnamen akt$0-42,400
-100.0%
-0.26%
VCEL ExitVERICEL CORP$0-67,049
-100.0%
-0.28%
ExitAMYLYX PHARMACEUTICALS INC$0-120,000
-100.0%
-0.29%
TWST ExitTWIST BIOSCIENCE CORP$0-160,000
-100.0%
-0.36%
ExitDICE THERAPEUTICS INC$0-80,000
-100.0%
-0.41%
CBAY ExitCYMABAY THERAPEUTICS INC$0-373,000
-100.0%
-0.45%
DXCM ExitDEXCOM INC$0-33,000
-100.0%
-0.47%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-57,800
-100.0%
-0.56%
TMDX ExitTRANSMEDICS GROUP INC$0-74,200
-100.0%
-0.69%
BBIO ExitBRIDGEBIO PHARMA INC$0-364,000
-100.0%
-0.70%
THTX ExitTHERATECHNOLOGIES INC$0-9,325,511
-100.0%
-0.87%
ANGO ExitANGIODYNAMICS INC$0-768,500
-100.0%
-0.89%
ILMN ExitILLUMINA INC$0-45,900
-100.0%
-0.96%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-97,547
-100.0%
-1.11%
SGEN ExitSEAGEN INC$0-71,000
-100.0%
-1.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ESSA PHARMA INC16Q3 202310.8%
IRADIMED CORP16Q3 20235.8%
XENON PHARMACEUTICALS INC15Q3 20232.9%
IVERIC BIO INC14Q1 20236.5%
SURMODICS INC14Q3 20234.7%
NATERA INC13Q3 20233.9%
DEXCOM INC13Q2 20234.2%
NOVOCURE LTD13Q3 20233.4%
CRISPR THERAPEUTICS AG13Q2 20232.6%
LYRA THERAPEUTICS INC13Q3 20231.0%

View Soleus Capital Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Soleus Capital Management, L.P.'s complete filings history.

Compare quarters

Export Soleus Capital Management, L.P.'s holdings